The clastogenic effect of 5-methoxypsoralen plus UV-A in human lymphocytes in vitro and its modification by the anticlastogen beta-aminoethylisothiouronium

Hum Genet. 1987 Jun;76(2):181-5. doi: 10.1007/BF00284918.

Abstract

The treatment of human lymphocytes in vitro with 5-methoxypsoralen (5-MOP) plus UV-A induces a dose-dependent increase in the SCE rate and in structural chromosome aberrations. We carried out tests to see whether the clastogenic effect of 5-MOP plus UV-A could be reduced by the anticlastogen beta-aminoethylisothiouronium (AET). The occurrence of a protective effect proved to be dependent upon the conditions of treatment. When AET was present over a long period of time (22 h) in cultures with 5-MOP, the number of breaks was reduced compared with such cultures without AET (reduction factor 0.5-0.6). On the other hand, a short period of action by AET (1.5 h) in the presence of 5-MOP produced no reduction of breaks. Posttreatment with AET (20 h) yielded an obvious protective effect (reduction factor 0.2-0.4). The possible mechanisms of the protective effect of AET are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Methoxypsoralen
  • Chromosome Aberrations / drug effects*
  • Chromosome Aberrations / radiation effects
  • Humans
  • Lymphocytes / drug effects*
  • Lymphocytes / ultrastructure
  • Methoxsalen / adverse effects*
  • Methoxsalen / antagonists & inhibitors
  • Mutagenicity Tests
  • Mutagens*
  • Sister Chromatid Exchange / drug effects
  • Sister Chromatid Exchange / radiation effects
  • Ultraviolet Rays
  • beta-Aminoethyl Isothiourea / pharmacology*

Substances

  • Mutagens
  • beta-Aminoethyl Isothiourea
  • 5-Methoxypsoralen
  • Methoxsalen